On May 8, 2015, Capstone Therapeutics Corp. announced that Fangmann was introduced and recommended to the Board as a nominee for director by Lloyd I. Miller, III, a significant shareholder. In addition, the Company announced that the Board views Fangmann's diverse financial experience brings important experience to the Board and qualifies him to serve on the Company's Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.2 USD | -.--% | -.--% | -.--% |
Apr. 01 | Capstone Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Capstone Holding Corp. Announces Change in Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 820K | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CAPS Stock
- News Capstone Holding Corp.
- Capstone Therapeutics Qualifies Fangmann to Serve on the Company’s Board